Hyponatremia: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett |
||
Line 5: | Line 5: | ||
==Treatment== | ==Treatment== | ||
[[Tolvaptan]] can be used for [[hyponatremia]].<ref>(2009) [http://www.medicalletter.org/restricted/articles/w1326c.html Tolvaptan (Samsca) for Hyponatremia] The Medical Letter</ref> | [[Tolvaptan]], a [[vasopressin]] receptor antagonist, can be used for [[hyponatremia]].<ref>(2009) [http://www.medicalletter.org/restricted/articles/w1326c.html Tolvaptan (Samsca) for Hyponatremia] The Medical Letter</ref><ref name="pmid20538391">{{cite journal| author=Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L, Gafter U| title=Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. | journal=Am J Kidney Dis | year= 2010 | volume= 56 | issue= 2 | pages= 325-37 | pmid=20538391 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20538391 | doi=10.1053/j.ajkd.2010.01.013 }}</ref> However, [[vasopressin]] receptor antagonist may increase the frequency of rapid sodium correction although [[osmotic demyelination syndrome]] may not be increased.<ref name="pmid20538391"/> | ||
==References== | ==References== | ||
<references/> | <references/> |
Revision as of 06:28, 18 September 2010
Diagnosis
Experienced physicians have difficulty in determining the underlying causes of hyponatremia.[1]
Treatment
Tolvaptan, a vasopressin receptor antagonist, can be used for hyponatremia.[2][3] However, vasopressin receptor antagonist may increase the frequency of rapid sodium correction although osmotic demyelination syndrome may not be increased.[3]
References
- ↑ Fenske W, Maier SK, Blechschmidt A, Allolio B, Störk S (2010). "Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study.". Am J Med 123 (7): 652-7. DOI:10.1016/j.amjmed.2010.01.013. PMID 20609688. Research Blogging.
- ↑ (2009) Tolvaptan (Samsca) for Hyponatremia The Medical Letter
- ↑ 3.0 3.1 Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L, Gafter U (2010). "Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.". Am J Kidney Dis 56 (2): 325-37. DOI:10.1053/j.ajkd.2010.01.013. PMID 20538391. Research Blogging.